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Placental Heat Shock Protein 70 Overexpression Confers
Resistance Against Oxidative Stress in Preeclampsia
Aims: Preeclampsia is a hypertensive disorder of human pregnancy and a leading cause of premature delivery
and fetal growth retardation. The purpose of this study was to evaluate the expression of heat shock protein
70 (HSP70), both constitutive (HSC70) and induced (HSP70) forms, along with oxidative stress status in the
placental tissues of normotensive (control group) and preeclamptic pregnancies.
Materials and Methods: Placental samples were collected after delivery from normotensive pregnancies and
preeclamptic patients (n = 20, each). Lipid peroxidation product malondialdehyde (MDA) and nitrite and nitrate
levels, along with antioxidants such as superoxide dismutase (SOD) and glutathione peroxidase (GPx) and
glutathione were estimated in the placental homogenate to evaluate the oxidative stress.
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Results: Placental tissue MDA levels and concentrations of nitrite and nitrate were significantly higher in the
preeclamptic group (P < 0.001) than the control group. Placental SOD and GPx activities and the reduced
glutathione (GSH)/oxidized glutathione (GSSG) ratio were significantly lowered in the preeclamptic (P <
0.001) group than the control group. Both placental HSC70 and HSP70 were in significantly higher
concentrations in the preeclamptic (7.25 ± 0.76, 27.67 ± 2.32 ng/mg protein; P < 0.001) than the control
(5.23 ± 0.64, 17.47 ± 1.22 ng/mg protein) group, respectively.
Conclusions: The above data provide the first evidence that high levels of HSP70 are associated in the
placenta of pre-eclamptic women. This enhanced expression is probably to exhibit its multiple protective effects
on the cell’s response to stress.
Key Words: Preeclampsia, peroxynitrite, superoxide dismutase, placenta, HSP70, oxidative stress,
antioxidants

Preeklampside Artm›ﬂ Plasental Heat Shock Protein 70 Ekspresyonu
Oksidatif Strese Karﬂ› Direnç Göstergesidir
Amaç: Preeklampsi gebelik s›ras›nda görülen ve fötusda geliﬂme gerili¤i veya premature do¤umlara yol
açabilen bir hipertansif hastal›kt›r. Bu çal›ﬂmada, normotansif ve preeklamptik gebeliklerde plasental dokuda
oksidatif stress düzeyi ve hem yap›sal hem de indüklenmiﬂ heat shock protein 70 (HSP70) ekspresyonunun
ölçülmesi amaçlanm›ﬂt›r.
Yöntem ve Gereç: Normotansif ve preeklamptik do¤um sonras› plasental örnekler (n = 20) al›nd›. Plasendal
dokuda s›ras›yla MDA, SOD, GPx, GSH ve GSSG ve nitrit/nitrat düzeyleri çal›ﬂ›ld›.
Bulgular: Preeklamptik grupta plasental dokuda HSC70 ve HSP 70, MDA ve nitrit/nitrat konsantrasyonlar›
control grubundan daha yüksekti (P < 0.01). Plasental SOD, GPx aktiviteleri ve GSH/GSSG oran› preeklamptik
grupta control grubundan daha düﬂüktü (P < 0.001). Hem HSC70 hem de HSP70 düzeyleri preeklamptik
grupta control grubundan daha yüksekti (s›ras›yla 7.25 ± 0.76, 27.67 ± 2.32 ng/mg vs 5.23 ± 0.64,
17.47 ± 1.22 ng/mg protein).
Received: May 04, 2007
Accepted: November 15, 2007

Sonuç: ‹lk kez bu çal›ﬂma ile preeklamptik kad›nlar›n plasentalar›nda HSp70 düzeylerinde art›ﬂ oldu¤u
saptanm›ﬂt›r. Bu artm›ﬂ ekspresyon muhtemelen hücrenin strese karﬂ› bir çok korunma yan›t› nedeniyledir.
Anahtar Sözcükler: Preeklampsi, peroksinitrit, superoksit dismutaz, placenta, HSP70, oksidatif stress,
antioksidanlar
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Introduction
Preeclampsia is a pregnancy-specific multisystem disorder that is characterized by
the development of hypertension and proteinuria after 20 weeks of gestation.
Preeclampsia is associated with increased risk of placental abruption, acute renal failure,
cerebrovascular complications and maternal death (1). Several studies carried out during
recent years have clearly demonstrated the pathophysiological basis of the disease (2).
The symptoms of the pathophysiological changes that occur in the disorder are the
27

PADMINI, E et al.

Placental HSP70 Expression in Preeclampsia

diagnostic criteria for preeclampsia (hypertension and
proteinuria); however, the development of the disease
and the risk factors that render a pregnant woman more
susceptible to develop preeclampsia are not clear (3,4).
Evidence points to the placenta as a key source of
factors that lead to these changes in preeclampsia (5). It
is generally hypothesized that placental changes are
induced by hypoxia. This may be a primary event or a
secondary effect of altered placental oxygenation in
preeclampsia. Oxidative stress may be the point at which
multiple etiological factors converge, resulting in
endothelial cell dysfunction and the consequent clinical
manifestations of preeclampsia.
Lipid peroxidation products produced by vascular
endothelial cells are candidate factors that may mediate
disturbance of maternal vascular endothelium. They can
deplete enzymatic and low molecular weight cellular
antioxidants, which in turn reduce the termination of free
radical lipid propagation reaction. The placenta is also
known to produce nitric oxide (NO), which has
pronounced effects on placental function including
trophoblast proliferation, differentiation and vascular
reactivity. NO is an unstable but multifunctional molecule
that mediates a number of diverse physiological and
pathological processes in endothelial cells. For example,
•
•
NO outcompetes superoxide dismutase (SOD) for O2 .
Peroxynitrite formation is favored while the peroxynitrite
anion is capable of nitrating proteins and inducing lipid
peroxides (6). Oxidant metabolites of NO can also deplete
enzymatic and low molecular weight cellular antioxidants.
There is experimental support for the role of oxidative
stress as a mediator of cell dysfunction and cell death (7).
In normal pregnancies, there is an increase in free
radical production and lipid peroxidation towards the end
of pregnancy when compared with non-pregnant women.
At the same time, the antioxidant capacity gradually
increases during pregnancy, leading to oxidative balance
maintenance during pregnancy (8). In pathogenic
pregnancies like preeclampsia, excessive production of
reactive oxygen species (ROS) may occur at certain
windows in placental development leading to reperfusion
injury. This leads to accumulation of placental debris
through apoptosis (9). However, the protective role
adopted by placental cells under these stressed conditions
is unknown.
Heat shock proteins (HSPs) have been recognized for
some years to protect the cells from various cytotoxic
28
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insults. HSPs are a group of inducible proteins, some of
which are constitutively expressed and increase in
response to stress, whereas others are expressed only
after stress. The constitutively expressed proteins act as
chaperones for other cellular proteins, binding to nascent
polypeptide to prevent premature folding and to
translocate proteins in to organelles (10). The induction
of increased levels of the stress proteins is associated with
the exposure to stress agents. The induced stress proteins
can act to protect cells from stress-induced damage by
preventing protein denaturation and/or by repairing such
damage. The aim of the present investigation was to
evaluate the oxidative stress and nitrative stress along
with HSP70 expression in the placenta of normal
pregnant and preeclamptic pregnant women. The results
can provide information about the defensive mechanism
adopted by the placenta during preeclamptic
pathophysiology.

Materials and Methods
Subjects
Patients registered in the Department of Obstetrics
and Gynecology of a private hospital in Chennai were
enrolled in this study. The study was carried out for a
period of one year. The sample consisted of 20 patients
aged 20-40 years. Patients with preeclampsia were
defined on the basis of the following clinical and
laboratory criteria: systolic blood pressure ≥140 mmHg
and diastolic blood pressure ≥ 90 mmHg but blood
pressure less than 160/110 mmHg noted on at least two
occasions; proteinuria levels > 300 mg/dl found in at least
two random specimens; and the activity of xanthine
oxidase of about 2.6 units/mg protein. Age-matched
healthy volunteers who were normotensive, of similar
gestational age, race, and body mass index (BMI) and
without maternal and fetal complications during the
pregnancy period were selected as control subjects.
Health was defined as the absence of major medical or
surgical disease and no need for regular medication.
Gestational age was defined based on last menstrual
period and ultrasonography. Furthermore, all the
patients were consulted by the internal medicine
department. There were 18 vaginal deliveries and 2
cesarean sections in the control group and 15 vaginal
deliveries and 5 cesarean sections in the preeclamptic
group. The clinical characteristics of the preeclamptic
patients were tabulated and compared with the
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normotensive pregnant subjects and the data are
presented in Table 1.
Immediately after delivery, the placental tissue
samples (2 to 3 g each) about 2-3 cm from the margin
were collected from 20 each preeclamptic patients and
normal pregnant women from the maternal side of the
placenta in a sterilized container and processed for tissue
homogenate preparation. The proposed plan of work was
approved by the Ethical Committee of the private hospital
in Chennai and the samples were collected with the
consent of each patient.
Preparation of Tissue Homogenates
About 1 g of placental tissue piece was weighed,
washed with ice cold physiological saline and cut in to 12 mm pieces and homogenized in ice–cold
homogenization buffer (150 mM NaCl, 50 mM Tris HCl
of pH 7.4, 1 mM EDTA, 1 mM PMSF, 1% Triton X-100,
1% sodium deoxycholic acid, 0.1% SDS, 5 µg/ml
aprotinin and 5 µg/ml of leupeptin) with the use of a
Teflon homogenizer. Homogenates were stored at –20
°C for later western blotting. Protein concentration of
these samples was determined by the method of Bradford
with the use of bovine serum albumin as the standard
(11). Aliquots of homogenates were then used for the
analysis of lipid peroxides, estimation of NO2- and NO3-,
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assay of SOD and glutathione peroxidase (GPx) activity
and the western blotting of HSP70.
Analysis of Oxidative Stress Markers

Estimation of malondialdehyde by HPTLC
The placental malondialdehyde (MDA) level, which is
the end product of lipid peroxidation, was measured by
high performance thin layer chromatography (HPTLC)
analysis. The HPTLC analysis of MDA was performed
according to the method of Carbonneau et al. (12) using
CAMAG TLC software.
The HPTLC analysis of MDA was performed using the
MDA/TBA (thiobarbituric acid) chromogen prepared
according to the method of Lykkesfeldt (13), which is as
follows: 40 µl of placental tissue homogenate was
suitably diluted with H2O and mixed with 20 µl of 2.8
mmol/L BHT (butylated hydroxy toluene) in ethanol, 40 µl
SDS and 600 µl of TBA reagent pH 3.5. The mixture was
immediately heated (60 min at 95 °C) and cooled with
running water. After vigorous mixing with 200 µml of
H2O, the clear supernatant was separated by
centrifugation. The product was then analyzed on a 2 mm
thick Silica gel G coated aluminium plate (Merck, Silica Gel
60F254, Germany). The plate was developed using
chloroform: methanol: water 65:25:4 and dried at room

Table 1. Clinical characteristics of the normotensive pregnant women and preeclamptic patients.
Characteristics

Normal Pregnancy
(n = 20)

Preeclamptic Pregnancy
(n = 20)

Maternal Age (Years)
Gestational Age

24.7 ± 2.7
37.8 ± 0.4

21.5 ± 1.4
32.3 ± 2.4

Prepregnancy Weight (kg)

50.1 ± 4.2

60.8 ± 4.8

Pregnancy Weight (kg)
Pre-pregnancy BP (mmHg)
Systolic
Diastolic

54.3 ± 7.6

69.1 ± 8.1

113.4 ± 5.8
76.8 ± 5.2

115.2 ± 6.2
77.1 ± 4.8

Pregnancy BP at 20 weeks (mmHg)
Systolic
Diastolic

114.7 ± 7.8
77.5 ± 4.1

151.4 ± 18.1
101.52 ± 9.3

Pregnancy BP at term (mmHg)
Systolic
Diastolic

120.8 ± 8.2
80.4 ± 7.1

165.8 ± 8.2
109.1 ± 7.3

1.9 ± 0.85

1

3.28 ± 0.20

2.42 ± 0.68

Parity
Infant Birth Weight
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temperature and the naturally colored spot was then
scanned with a Camag TLC Scanner II (Camag, Muttenz,
Switzerland) in the reflectance mode at 366 nm coupled
with an SP 4100 integrator. The results were expressed
as nanomoles of MDA formed /mg protein.

Measurement of nitrite (NO2-) and nitrate (NO3-)
Placental tissue homogenate nitrite and nitrate were
estimated by the method of Yokoi et al. (14) with slight
modifications using Griess reagent, which relies on a
colorimetric reaction between nitrite, sulphanilamide and
N-(1-naphthyl ethylene diamine dihydrochloride to
produce a pink azo product, which was measured at 520
nm. For the nitrate estimation, prior to the addition of
Griess reagent, all nitrate was converted to nitrite using
cadmium sulphate and copper sulphate. Concentrations
were determined by comparison to a standard solution of
sodium nitrite. The levels of nitrate can be obtained by
subtracting the value of nitrite (nitrate converted to
nitrite) from total nitrite content. The levels of NO2 and
NO3 were expressed as micromoles per gram tissue
protein.
Analysis of Enzymatic Antioxidants

Assay of superoxide dismutase
The activity of SOD was assayed by monitoring the
oxidation of epinephrine by SOD at 420 nm for 3 min at
30 sec time interval according to the procedure of Mistra
et al. (15). Auto oxidation of epinephrine was also
monitored in the reaction mixture without adding the
enzyme source, which serves as blank. The activity of the
enzyme was expressed as units of SOD/min/mg protein.

Assay of glutathione peroxidase
The activity of GPx was assayed according to the
method of Rotruck et al. (16). The suitably prepared
tissue extract was assayed for glutathione content using
DTNB at 412 nm. The activity of GPx is expressed as
micromoles of glutathione consumed /min/mg protein.
Estimation
of
Spectrofluorometry

GSH/GSSG

Ratio

by

The glutathione status was assessed by the method of
Hissin and Hilf (17). This method is based on the reaction
of O-phthaldehyde (OPT) as a fluorescent reagent with
reduced glutathione (GSH) at pH 8.0 and oxidized
glutathione (GSSG) at pH 12.0, which involves excitation
at 350 nm and fluorescence at 420 nm. For the GSSG
estimation, GSSG was complexed to N-ethylmaleimide
30
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(NEM) to prevent interference of GSH with the
measurement of GSSG. The values were expressed as
nanomoles/mg of protein.
Western Blotting of HSP70
The western blotting was performed according to the
method of Towbin et al. (18) with a slight modification.
The placental homogenate (100 µg of protein) was
analyzed with the use of SDS-polyacrylamide gel
electrophoresis (10%) according to Laemmli method
(19). After electrophoresis, the gel was blotted on to a
PVDF membrane (Biotrace; Germany), blocked with 5%
Blotto overnight with agitation and then probed with a
mouse alkaline phosphatase conjugated monoclonal
antibody raised against HSP70 (SPA –820; Stressgen,
Canada) diluted in PBS buffer. This antibody recognizes
both the inducible and cognate forms of HSP70. The
BCIP-NBT substrate (Sigma, St. Louis, MO) system was
used to detect the alkaline phosphatase conjugate as
described by the manufacturer. All immunoblots for
HSP70 showed a doublet of bands. Apart from those
bands, the antibodies did not cross-react with any protein
on the membrane. The band intensities were scanned
with the HP Scan Imager and quantified using the
TotalLab Software, Germany.
Statistical Analysis
All data were expressed as mean value ± SD. The
values were subjected to statistical analysis using normal
tests of significance. For the statistical analysis, normal
subjects were compared with preeclamptic patients using
Wilcoxon Mann-Whitney test. The SPSS software package
version 7.0 was used to test the significance of the
experiments performed.

Results
Figure 1 represents the HPTLC profiles of the lipid
peroxidative product MDA in the placental tissue of the
preeclamptic patients and of the normal pregnant
women.
The levels of MDA and NO metabolites NO2- and NO3in the placental tissue of the preeclamptic patients and of
the normal healthy volunteers are presented in Table 2.
The MDA levels were significantly higher in the
preeclamptic (4.12 ± 0.32 nmol/mg protein; P < 0.001)
than the control (2.78 ± 0.12 nmol/mg protein) group.
Placental tissue nitrite and nitrate were significantly

Vol: 38

Placental HSP70 Expression in Preeclampsia

No: 1

[mV]100
80
60
40
20
0

Table 3. Levels of the activities of SOD and GPx enzymes in the
placental tissue of the preeclamptic patients and of the
normal healthy volunteers.

2

1

SOD
(units/min/
mg protein)

GPx
(µmol of glutathione
consumed/min/
mg protein)

Normotensive pregnant
women

4.45 ± 0.22

0.94 ± 0.047

Preeclamptic women

1.94 ± 0.17*

0.48 ± 0.035*

Subjects

0.0
Wavelength: 366 nm
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Figure 1. HPTLC analysis of MDA/TBA chromogen in the placental
tissues of normotensive pregnant women and patients with
preeclampsia.
Absorption spectra of MDA/TBA chromogen. Scans carried
out in reflectance mode at 366 nm.
1
MDA/TBA Chromogen of normal pregnant women.
2
MDA/TBA Chromogen of preeclamptic patients.

SOD: superoxide dismutase. GPx: Glutathione peroxidase.
Values are expressed as mean ± S.D for 20 individuals in each group.
*P < 0.001, compared with normotensive pregnancy.
80

Table 2. Levels of MDA and nitric oxide metabolites NO2- and NO3- in
the placental tissue of the preeclamptic patients and of the
normal healthy volunteers.
NO2
(µmol/
g protein)

-

NO3(µmol/
g protein)

Normotensive
pregnant women

2.78 ± 0.12

2.3 ± 0.1

3.1 ± 0.3

Preeclamptic
women

4.12 ± 0.32*

5.4 ± 0.4*

7.2 ± 0.5*

GSH/GSSG Ratio

MDA
(nanomoles/
g protein)

Subjects

70

60

50

40

Values are expressed as mean ± S.D for 20 individuals in each group.
NO2-: Nitrite. NO3-: Nitrate.
*P < 0.001, when compared with normotensive pregnancy.

higher in the preeclamptic (5.4 ± 0.4 and 7.2 ± 0.5
mmol/gram protein; P < 0.001) than in the control (2.3
± 0.1 and 3.1 ± 0.3 mmol/gram protein, P < 0.001)
group, respectively.
As shown in Table 3, the placental SOD and GPx
activities were significantly lower in the preeclamptic
(0.94 ± 0.17 units/min/mg protein, 0.48 ± 0.035 mmol
of glutathione consumed/min/mg protein; P < 0.001)
than in the control (4.45 ± 0.22 units/min/mg protein,
1.94 ± 0.047 mmol of glutathione consumed/min/mg
protein) group, respectively.
Figure 2 shows the box plot of the GSH/GSSG ratio in
placental tissue of the preeclamptic patients and of the
normal healthy volunteers. The GSH/GSSG ratio was
significantly decreased (46.67 ± 2.41; P < 0.001) in the
preeclamptic patients compared to the control group
(68.23 ± 2.41).

30
N=

20
Normal Pregnant

20
Preeclamptic Patient

Figure 2. Box plot of the GSH/GSSG in the placental tissue of the
normotensive pregnant women and preeclampsia patients.
*P < 0.001, compared to normotensive pregnant women.

Figure 3 shows the western blot of HSP70 of the
placental tissue of the preeclamptic patients and of the
normal healthy volunteers. Overall there was a multi-fold
increase in the expression of both constitutive and
inducible forms of HSP70 in the preeclamptic patients
when compared to normal healthy volunteers. The
placental HSC70 and HSP70 levels were in significantly
higher concentrations in the preeclamptic (7.25 ± 0.76,
27.67 ± 2.32 ng/mg protein; P < 0.001) than in the
control (5.23 ± 0.64, 17.47 ± 1.22 ng/mg protein)
group, respectively.

Discussion
Preeclampsia develops as a consequence of an
exceptionally complex interaction between a multiplicity
31
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keeping the uteroplacental circulation in a state of high
resistance and leading to reduced uteroplacental
perfusion and focal regions of hypoxia. These changes
may cause blood flow to remain under vasomotor
control. We have earlier reported atherosis, fibroid
necrosis and infarction in the placenta of preeclamptic
patients (20). This results in large fluctuations in
intervillous oxygen concentration leading to ischemic
reperfusion phenomenon with overproduction of ROS
(21). This study confirms that in preeclampsia, lipid
peroxidation is increased significantly when compared to
healthy pregnant women.

Concentration in nanogram/
mg protein

LEVEL OF HSC70 AND HSP70 IN CONTROL AND PREECLAMPTIC PATIENS
35
*

30
25
20
15
10
5
0
Normotensive Pregnant Women

(b)

HSC70

Preeclampsia Patients
HSP70

Figure 3. (a) Western blot of HSP70 of the placental tissue of the
normotensive pregnant women and patients with
preeclampsia, (b) Histogram of HSP70 of the placental
tissue of the normotensive pregnant women and
preeclampsia patients.
*P < 0.001 compared to normotensive pregnant women.

of factors that originate in two genetically different
individuals (the mother and the fetus). Oxidative stress
may represent one group of such factors as shown from
this study. In the women with established preeclampsia,
lipid peroxide product MDA increased and enzymatic
antioxidants SOD and GPx as well as non-enzymatic
antioxidant glutathione were decreased. In healthy
pregnant women, the total antioxidant capacity
(enzymatic and non-enzymatic) is maintained as a
compensatory balance of the injury/defense against lipid
peroxidation products, allowing oxidative equilibrium to
persist throughout pregnancy. Preeclamptic women fail
to develop this compensatory mechanism. In normal
pregnancies, there is remodeling at the placental vascular
bed. Here cytotrophoblasts invade the maternal spiral
arteries feeding the intervillous space involving the
endothelium, making them lose their smooth muscle. This
becomes sinusoids, a type of vessel with large capacity
and low resistance lacking any contractibility. In
preeclampsia, these physiological changes are drastically
affected. The trophoblastic invasion is very shallow,
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During preeclampsia, the levels of NO in the placenta
are also increased. Under conditions of oxidative stress,
the oxygen free radical, superoxide anion will
preferentially react with available NO, increasing the
formation of peroxynitrite in tissues (22). This study
evidences the reduction of antioxidant capacity in
preeclamptic women. The low SOD activity shown in the
preeclamptic patients may be explained by the lack of
induction for production of SOD, since superoxide anion
reacts with NO to produce high peroxynitrite levels (23).
The major biological end products of •NO metabolism are
nitrite NO2 , and nitrate NO3 , both of which are excreted
in the urine. During metabolism to NO2-/NO3-, NO can
undergo a series of reactions that generate reactive
nitrogen species having a variety of oxidative states. NO
reacts with superoxide O2• to form peroxynitrite (ONOO-).
ONOO- is a highly reactive species that reacts with
proteins, lipids, carbohydrates and DNA of subcellular
organelles and cell system through oxidation and nitration
mechanisms (24). Peroxynitrite is known to induce
nitration of tyrosine residues on proteins, thus altering its
function. Peroxynitrite formation has been observed in
the maternal vasculature of women with diabetes (23).
GPx and enzymatic antioxidant decrease lipid peroxide
by reducing hydroperoxides to alcohols. The reactive
•
+
nitrogen species ONOO yields more nitrosonium ion NO
that is responsible for oxidizing the selenocysteine residue
of GPx to a selenylsulfide having a free thiol thereby
inactivating the enzyme (25). Once GPx is inhibited, it can
no longer scavenge peroxides and terminate propagating
lipid oxidation reaction. Therefore, lipid peroxide
reactions can be expected to increase as seen from our
studies. In addition to inhibiting GPx, ONOO• also oxidizes
GPx-reducing cofactor glutathione (26). By impairing
cellular defenses against lipid peroxidation through the
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depletion of antioxidants and inhibition of GPx, oxidation
reactions can greatly increase the rate of lipid
peroxidation. The impairment of NO-mediated endothelial
function and the accumulation of oxidized lipids in the
vessel wall are central pathological events in endothelial
dysfunction. Nitrative stress in preeclampsia may also
alter placental function via increased trophoblast
apoptosis.
Overexpression of HSP is an important means of cell
protection during physiological stress such as that
occurring during apoptosis. As metabolically active tissues
vital to the maintenance of pregnancy, it is probable that
placental tissue, particularly in preeclampsia, experiences
overstress and this may be the reason for the boost in the
production of HSP70. NO has a powerful effect on
maternal blood vessels and its release is partly mediated
by the HSP90 (27). It had been reported that abundance
of HSP70 may modulate uterine function in response to
stress (28). Adrie et al. (29) have also demonstrated that
•
NO/•ONOO represents a strong stress to human
monocytes leading to increase in HSP70. Increased
expression of HSP70 may allow proliferating endothelial
cells in the placenta an increased chance of survival.
The data reported by Xu et al. (30) suggested that
HSP could play a role in the repair of denatured proteins
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modified by NO and in folding of nascent polypeptide
chains. Thus, HSP70 is likely to be important in
maintaining homeostasis during NO and oxidative stress.
Overall, these observations suggest that NOs and free
radicals may induce an unrecognized primary line of
defense via elevation of HSP70 against oxidative stresses
and protect the cell from apoptosis in preeclampsia. In
conclusion, these data provide the first evidence that high
levels of HSP70 are associated in the placenta of
preeclamptic women. This enhanced expression is
probably to exhibit its multiple protective effects on the
cell’s response to stress.

Perspectives
The present study is the first, to our knowledge, to
assess the overexpression of the constitutive and
inducible forms of HSP70 during the placental oxidative
stress that plays a pivotal role in preeclampsia. We have
demonstrated significant expression of HSPs during
placental oxidative and nitrosative stress in preeclampsia.
This study raises an additional question with regard to
how the overexpression of HSPs in placental cells confers
resistance to hemodynamic stress. Further research for
the answers will result in valuable clinical application for
preeclampsia.

References
1.

Mackay AD, Berg CJ, Atraske HK. Pregnancy related mortality
from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 5338.

9.

Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA.
Placental apoptosis in preeclampsia. Obstet Gynecol 2000; 96:
271-6.

2.

Roberts JM. Endothelial dysfunction in preeclampsia. Sem Reprod
Endocrinol 1998; 16: 5-15.

10.

3.

Higgins JR, Brennecke SP. Preeclampsia — still a disease of
theories? Curr Opin Obstet Gynecol 1998; 10: 129-33.

Katherine AB, Giaccia AJ, Killender M, Anderson RL. Heat shock
protein 72 modulates pathways of stress induced apoptosis. J Biol
Chem 1998; 273(27): 17147-54.

11.

4.

Lana KW. Diagnosis and management of preeclampsia. Am Fam
Physician 2004; 70: 2317-24.

Bradford M. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of
protein–dye binding. Anal Biochem 1976; 72: 248-54.

5.

Blem A, Shenhav M, Baruch R, Hoffman M. Endothelial
dysfunction in preeclampsia and eclampsia. Current etiology and
future – non-invasive assessment. IMAJ 2003; 5: 724-6.

12.

Carbonneau MA, Peuchant E, Sess D, Canioni P, Clerc M. Free and
bound malondialdehyde measured as thiobarbituric acid adduct by
HPLC in serum and plasma. Clin Chem 1991; 37(8): 1423-9.

6.

Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a
biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;
411: 157-60.

13.

7.

Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide
production with preeclampsia. Obstet Gynecol 1999; 93: 442-5.

Lykkesfeldt J. Determination of malondialdehyde as
dithiobarbituric acid adduct in biological samples by HPLC with
fluorescence detection: comparison with ultraviolet visible
spectrophotometry. Clin Chem 2001; 47(9): 1725-7.

14.

Yokoi I, Habu H, Kabuto H, Mori A. Analysis of nitrite, nitrate,
nitric oxide synthase activity in brain tissue by automated flow
injection technique. Methods Enzymol 1996; 268: 152-9.

8.

Toescu V, Nuttall SC, Martin U, Kendall MJ, Dunne F. Oxidative
stress and antioxidants in normal pregnancy. Clin Endocrinol (Oxf)
2002; 57: 609-13.

33

PADMINI, E et al.

Placental HSP70 Expression in Preeclampsia

Turk J Med Sci

15.

Mistra HP, Fridovich I. The role of superoxide anion in the
autooxidation of epinephrine and simple assay for superoxide
dismutase. J Biochem 1972; 247: 3170-5.

23.

Roggensack A, Zhang Y, Davidge S. Evidence for peroxynitrite
formation in the vasculature of women with preeclampsia.
Hypertension 1999; 33: 83-9.

16.

Rotruck JT, Pope AC, Ganther HE, Swaon AB, Hafeman DG,
Hockstra WG. Selenium: biochemical rates as a component of
glutathione peroxidase. Science 1973; 179: 588-90.

24.

O’Donell VB, Freeman BA. Interactions between nitric oxide and
lipid oxidation pathways. Implications for vascular disease. Circ
Res 2001; 88: 12.

17.

Hissin PJ, Hilf R. A fluorometric method for the determination of
oxidized and reduced glutathione in tissues. Anal Biochem 1976;
74: 214-26.

25.

Asahi M, Fujii J, Suzuki K, Seo HG, Kuzoya T, Hori M et al.
Inactivation of glutathione peroxidase by nitric oxide. Implication
for cytotoxicity. J Biol Chem 1995; 270: 21035-9.

18.

Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets:
procedure and some applications. Proc Natl Acad USA 1979; 76:
4350-4.

26.

Radii R, Beckman JS, Buoh KM, Freeman BA. Peroxynitrite
oxidation of sulfhydryls, the cytotoxic potential of superoxide and
nitric oxide. J Biol Chem 1991; 266: 4244-50.

27.

19.

Laemmli UK. Cleavage of structural proteins during the assembly
of the head of bacteriophage T4. Nature 1970; 227: 680.

Garcia–Cardena G, Fan R, Shah V, Serrentino R, Grino GF,
Papapetropoulos A et al. Dynamic activation of endothelial nitric
oxide synthase by HSP 90. Nature 1998; 392: 821-4.

20.

Padmini E, Sowmya S. Atherosis: a major event in the
pathophysiology of preeclampsia. Biomedicine 2005; 25(3 & 4):
6-12.

28.

21.

Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ et al.
Effect of antioxidants on the occurrence of pre-eclampsia in
women at increased risk. A randomized trial. Lancet 1999; 354:
810-6.

Wu WX, Derks JB, Zhang O, Nathanielsz PW. Changes in HSP-90
& -70 mRNA in uterine tissues of the ewe in relation to
parturition and regulation by estradiol and progesterone.
Endocrinology 1996; 137(12): 5685-93.

29.

Adrie C, Richter C, Bachelet M, Banzet N, Francoi D, Dinh-Xuan T
et al. Contrasting effects of NO and peroxynitrites as HSP70
expression and apoptosis in human monocytes. Am J Physiol Cell
Physiol 2000; 279(2): C452-60.

30.

Xu Q, Hu Y, Kleindienst R, Wick G. Nitric oxide induces heat shock
protein 70 expression in vascular smooth muscle cells via
activation of heat shock factor 1. J Clin Invest 1997; 100: 108997.

22.

34

Lynn C, Cooke M, Davidge ST. Peroxynitrite increases through
iNOS through NF-B and decreases prostacyclin synthase in
endothelial cells. Am J Physiol Cell Physiol 2002; 282: C395C402.

